Atlas Trials

Jeffrey Clarke

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jeffrey Clarke

RecordFirmDate
Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer (NCT05617313)Jeffrey Clarke2023-02-17
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases (NCT04610684)Jeffrey Clarke2021-01-05
Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC (NCT03573947)Jeffrey Clarke2018-10-02
A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007 (NCT01061788)Jeffrey Clarke2010-04-01

Track Jeffrey Clarke automatically

Every clearance here is in the API, with alerts when new ones post.